MOORESTOWN, N.J., Nov. 08, 2018 — Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, recently completed the acquisition of healthcare technology company, Cognify.
Founded in San Francisco in 1998, Cognify is focused on enabling patient-centered, multidisciplinary, coordinated and integrated care along with financial management for the federal Program of All-inclusive Care for the Elderly (PACE) as well as Managed Long-term Care (MLTC) and medical home providers. Cognify’s expertise enables clients to seamlessly integrate turnkey software solutions for optimal business performance and participant outcomes.
According to TRHC Chairman and CEO, Calvin H. Knowlton, PhD, “The software and services of Cognify will continue to empower PACE organizations and track measurable outcomes in defined timeframes for the frail senior population we serve. Adding Cognify to TRHC amplifies our ability to develop scalable solutions to meet the needs of PACE and other at-risk payers, such as Medicare, Medicaid, and commercial health plans. We are confident our comprehensive, coordinated technology solutions will bring added value to our clients”.
Mace Wolf, formerly CEO of Cognify, will remain with the company and serve as CEO of Cognify-Mediture. Mediture is a leading Electronic Health Record (EHR) software solutions unit of TRHC’s technology and services division CareVention HealthCare.
About Tabula Rasa HealthCare®
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize patient outcomes, lower healthcare costs and improve organizational performance. Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers and other healthcare organizations. For more information, visit TRHC.com. Follow us on Twitter @TabulaRasaHC for up-to-date information.
This press release includes forward-looking statements that we believe to be reasonable as of today’s date including statements regarding risk stratification under the new scope of work. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 14, 2018, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website http://ir.trhc.com or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.
Bob East or Asher Dewhurst